During the past decade, Klinikum Nürnberg conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 6 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Nürnberg" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "GWT-TUD GmbH" with 3 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials sponsored, "University of Erlangen-Nürnberg Medical School" with 3 trials sponsored and "Corcym S.r.l" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Nürnberg" #1 collaborator was "German Research Foundation" with 3 trials as a collaborator, "Klinikum Nürnberg" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 126 different institutions and companies that were collaborators in the rest 136 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Nürnberg" are "Acute Coronary Syndrome" (2 trials), "Acute Myeloid Leukemia" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Klinikum Nürnberg" in a lesser frequency.

Most popular intervention types in "Klinikum Nürnberg" are "Drug" (24 trials), "Device" (10 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Azacitidine" (2 trials), "BI 1015550" (2 trials), "Carboplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Nürnberg" are 49 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Nürnberg". undefined are not yet recruiting, 17 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Klinikum Nürnberg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Nürnberg, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Klinikum Nürnberg has several departments that took part in Clinical trials: "Klinikum Nürnberg Nord; Hautklinik; Klinik für Dermatologie" - 5 trials, "Klinikum Nürnberg Süd / Cardiology" - 2 trials